Skip to content
A8836Assembly2021-2022 SessionSame asS7694

Screen Newborns for G6PD

Official title

“Relates to the screening of newborns for glucose-6-phosphate dehydrogenase deficiency”

Sponsor Richard GottfriedAD-75+1 co-sponsorAffects Health
Status
Assembly Floor Calendar
Impact
5/10
Moderate
Outcome
Companion signed

Bill progress

Signed via S7694

What's happening

This bill requires targeted newborn screening for glucose-6-phosphate dehydrogenase deficiency based on specific medical or ancestry-related risk factors.

Why it matters

  1. Targets screening toward high-risk newborns. Instead of universal testing, this bill focuses on infants with specific symptoms (like hemolytic anemia or persistent jaundice) or those with a family or ancestry-based risk, making screening more efficient and clinically relevant.

  2. Addresses health disparities. By explicitly including African, Asian, Mediterranean, and Middle Eastern ancestry as risk factors, the bill acknowledges and seeks to address the higher prevalence of G6PD deficiency in these populations, potentially reducing missed diagnoses among at-risk groups.

  3. May improve early detection and treatment. Catching G6PD deficiency in symptomatic or high-risk infants can prevent severe complications, such as dangerous jaundice or hemolytic crises, leading to better health outcomes and reduced healthcare costs.

  4. Requires updates to hospital protocols and training. Hospitals and healthcare providers will need to adjust their newborn screening procedures and ensure staff are trained to recognize risk factors and symptoms that now trigger mandatory testing.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Screen Newborns for G6PD

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Richard Gottfried

Assembly Member · Assembly District 75

1 Co-sponsor

History

  1. Substituted by S7694
  2. Advanced to third reading cal.353
  3. Reported
  4. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S7694Senate

Test Newborns for G6PD

Signed by Governor · Sponsor Gustavo Rivera

Impact 5 · ModerateSigned into law

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8836

IN ASSEMBLY

January 13, 2022

Introduced by M. of A. GOTTFRIED -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to newborn screening for glucose-6-phosphate dehydrogenase deficiency

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Paragraph (j) of subdivision 1 of section 2500-a of the public health law, as added by a chapter of the laws of 2021 amending the public health law relating to newborn screening for adrenoleukodystrophy and glucose-6-phosphate dehydrogenase deficiency, as proposed in legislative bills numbers A. 4572 and S. 4316, is amended to read as follows:

(j) Glucose-6-phosphate dehydrogenase deficiency using a quantitative enzymatic test or other diagnostic test in cases where: the newborn infant presents with hemolytic anemia, hemolytic jaundice, or early-onset increasing neonatal jaundice, that is, jaundice (bilirubin level greater than fortieth percentile for age in hours) persisting beyond the day of birth through the week after birth; the newborn infant has been admitted to the hospital for jaundice following birth; or the biological parent of the newborn infant indicates a family, racial, or ethnic risk of glucose-6-phosphate dehydrogenase deficiency, including having significant African, Asian, Mediterranean, or Middle Eastern ancestry.

§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2021 amending the public health law relating to newborn screening for adrenoleukodystrophy and glucose-6-phosphate dehydrogenase deficiency, as proposed in legislative bills numbers A. 4572 and S. 4316, takes effect. Effective immediately, the commissioner of health shall make regulations and take other actions reasonably necessary to implement this act on that date.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00136-02-2

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.